ClinConnect ClinConnect Logo
Search / Trial NCT03218215

Monitoring Mechanical Assisted Cough

Launched by CORPORACION PARC TAULI · Jul 12, 2017

Trial Information

Current as of July 23, 2025

Completed

Keywords

Cough Assits

ClinConnect Summary

A cross-sectional observational study was performed with patients with NMD who had PFC below 160l/min according to Mechanical insufflation- exsufflation (MI-E ) criteria to assit the cough.

Exclusion criteria were age \<18 years, patients who had undergone tracheostomy, exacerbated or with psychiatric problems and patients with relative contraindications (bullous emphysema background, risk of pneumothorax or recent barotrauma).

MI- E study protocol An original protocol was established to perform treatment assessment with Cough Assitst T70 MI-E device® Phillips Respironics. Protocol based ...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • patients with NMD who had PFC below 160l/min according to Mechanical insufflation- exsufflation (MI-E ) criteria to assit the cough.
  • Exclusion Criteria:
  • age \<18 years,
  • patients who had undergone tracheostomy, exacerbated or with psychiatric problems
  • patients with relative contraindications (bullous emphysema background, risk of pneumothorax or recent barotrauma).

About Corporacion Parc Tauli

Corporación Parc Taulí is a leading healthcare organization based in Sabadell, Spain, known for its commitment to advancing medical research and clinical excellence. With a focus on innovative healthcare solutions, the organization integrates cutting-edge technology and multidisciplinary collaboration to enhance patient outcomes. As a sponsor of clinical trials, Corporación Parc Taulí emphasizes ethical practices, rigorous scientific methodologies, and robust data management to contribute to the development of new therapies and improve healthcare standards. Their dedication to research and patient care positions them as a vital player in the clinical research landscape.

Locations

Patients applied

0 patients applied

Trial Officials

Manel Lujan, MD

Study Director

Corporacion Parc Tauli

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials